Structure based on 5i96 | Ideal structure |
|
Name: 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol |
Formula: C19 H17 F6 N7 O |
Weight: 473.375 |
SMILES: "CC(C)(O)CNc1nc(Nc2ccnc(c2)C(F)(F)F)nc(n1)c3cccc(n3)C(F)(F)F" |
Spacial conformation based on PDB
5i96 |
RESIDUE 69Q 50
CONECT C13 3 C15 C26 N10
CONECT C15 3 C13 C14 H1
CONECT C17 3 C16 C18 H2
CONECT C20 3 C21 N19 H3
CONECT C21 3 C20 C16 H4
CONECT C22 4 C24 C12 C23 O25
CONECT C24 4 C22 H5 H6 H7
CONECT C26 4 C13 F27 F28 F29
CONECT C01 3 N02 N03 C07
CONECT N02 2 C01 C05
CONECT N03 2 C01 C04
CONECT C04 3 N03 N06 N08
CONECT C05 3 N02 N06 N09
CONECT N06 2 C04 C05
CONECT C07 3 C01 N10 C11
CONECT N08 3 C04 C16 H8
CONECT N09 3 C05 C12 H9
CONECT N10 2 C13 C07
CONECT C11 3 C07 C14 H10
CONECT C12 4 C22 N09 H11 H12
CONECT C14 3 C15 C11 H13
CONECT C16 3 C17 C21 N08
CONECT C18 3 C17 N19 C30
CONECT N19 2 C20 C18
CONECT C23 4 C22 H14 H15 H16
CONECT O25 2 C22 H17
CONECT F27 1 C26
CONECT F28 1 C26
CONECT F29 1 C26
CONECT C30 4 C18 F31 F32 F33
CONECT F31 1 C30
CONECT F32 1 C30
CONECT F33 1 C30
CONECT H1 1 C15
CONECT H2 1 C17
CONECT H3 1 C20
CONECT H4 1 C21
CONECT H5 1 C24
CONECT H6 1 C24
CONECT H7 1 C24
CONECT H8 1 N08
CONECT H9 1 N09
CONECT H10 1 C11
CONECT H11 1 C12
CONECT H12 1 C12
CONECT H13 1 C14
CONECT H14 1 C23
CONECT H15 1 C23
CONECT H16 1 C23
CONECT H17 1 O25
END
HET 69Q 50
HETSYN 69Q Enasidenib; AG-221
HETNAM 69Q 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-
HETNAM 2 69Q (trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl
HETNAM 3 69Q )amino]propan-2-ol
FORMUL 69Q C19 H17 F6 N7 O